ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,101.24
      -0.29%
      US Tech 100
      20,394.80
      -3.73%
      Dow Jones
      44,424.25
      0.00%
      Brent Oil
      77.105
      -0.10%
      Bitcoin
      99,585.89
      -4.86%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. DBV Technologies (DBV) Quote

      DBV Technologies

      DBV Technologies (DBV)

      DBV Technologies
      Doubleview Capital Corp
      0.856
      -0.019
      ( -2.17% )
      Updated: 07:26:48
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.856
      Bid
      0.847
      Ask
      0.857
      Volume
      140,811
      0.84 Day's Range 0.884
      0.506 52 Week Range 1.816
      Market Cap
      80.59M
      Previous Close
      0.875
      Open
      0.884
      Last Trade
      300
      @
      0.856
      Last Trade Time
      07:26:30
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      801,627
      Shares Outstanding
      94,147,319
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      15.73M
      Net Profit
      -72.71M

      About DBV Technologies

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.dbv-technologies.com
      Headquarters
      Chatillon, Hauts-de-seine, Fra
      Founded
      -
      DBV Technologies is listed in the Pharmaceutical Preparations sector of the Euronext with ticker DBV. The last closing price for DBV Technologies was 0.88 €. Over the last year, DBV Technologies shares have traded in a share price range of 0.506 € to 1.816 €.

      DBV Technologies currently has 94,147,319 shares outstanding. The market capitalization of DBV Technologies is 82.38 € million.

      Ask ADVFN Intelligence (AI)

      DBV Latest News

      More News

      Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

      Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF AMF Regulated InformationChâtillon, France, January 13, 2025 Half-Year Report on the DBV Technologies Liquidity Contract...

      January 13 2025
      UK Regulatory

      Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

      Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF Informations RéglementéesChâtillon, France, le 13 janvier 2025 Bilan semestriel du contrat de liquidité DBV Technologies...

      January 13 2025
      UK Regulatory

      Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

      AMF Regulated InformationChâtillon, France, January 13, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 –...

      January 13 2025
      GlobeNewswire Inc.

      DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study

      DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study Châtillon, France, January 8th, 2025 DBV Technologies Announces Positive 3-Year Results from...

      January 08 2025
      UK Regulatory

      DBV Technologies présente les résultats positifs à 3 ans de l'étude de prolongation en ouvert d 'EPITOPE, étude clinique de phase 3

      DBV Technologies présente les résultats positifs à 3 ans de l'étude de prolongation en ouvert d 'EPITOPE, étude clinique de phase 3 Châtillon, France, le 8 janvier (22 :15 CEST) 2025 DBV...

      January 08 2025
      UK Regulatory

      DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study

      Châtillon, France, January 8th, 2025 DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in...

      January 08 2025
      GlobeNewswire Inc.

      DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

      DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old Châtillon, France, December 11th, 2024 DBV Confirms Alignment with...

      December 11 2024
      UK Regulatory

      DBV confirme l’alignement avec la FDA (US) sur la procédure d'approbation accélérée du patch Viaskin® Peanut chez les enfants âgés de 1 à 3 ans

      DBV confirme l’alignement avec la FDA (US) sur la procédure d'approbation accélérée du patch Viaskin® Peanut chez les enfants âgés de 1 à 3 ans Châtillon, France, le 11 décembre (22 :05 CEST...

      December 11 2024
      UK Regulatory

      DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

      Châtillon, France, December 11th, 2024 DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old DBV and FDA aligned on key...

      December 11 2024
      GlobeNewswire Inc.

      Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 novembre 2024

      Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 novembre 2024                                                                Information...

      December 02 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.031-3.494926719280.8870.9250.843859680.89200511DE
      40.20832.09876543210.6481.160.62111187320.92285074DE
      120.08611.16883116880.771.160.5068016270.7946334DE
      26-0.053-5.830583058310.9091.470.5064590740.80637845DE
      52-0.949-52.57617728531.8051.8160.5062848480.88671785DE
      156-1.916-69.11976911982.7725.480.5062115472.14150519DE
      260-17.774-95.405260332818.6321.220.5063666345.28487111DE

      DBV - Frequently Asked Questions (FAQ)

      What is the current DBV Technologies share price?
      The current share price of DBV Technologies is 0.856 €
      How many DBV Technologies shares are in issue?
      DBV Technologies has 94,147,319 shares in issue
      What is the market cap of DBV Technologies?
      The market capitalisation of DBV Technologies is EUR 82.38M
      What is the 1 year trading range for DBV Technologies share price?
      DBV Technologies has traded in the range of 0.506 € to 1.816 € during the past year
      What is the reporting currency for DBV Technologies?
      DBV Technologies reports financial results in USD
      What is the latest annual turnover for DBV Technologies?
      The latest annual turnover of DBV Technologies is USD 15.73M
      What is the latest annual profit for DBV Technologies?
      The latest annual profit of DBV Technologies is USD -72.71M
      What is the registered address of DBV Technologies?
      The registered address for DBV Technologies is 107 AVENUE DE LA REPUBLIQUE, CHATILLON, HAUTS-DE-SEINE, 92120
      What is the DBV Technologies website address?
      The website address for DBV Technologies is www.dbv-technologies.com
      Which industry sector does DBV Technologies operate in?
      DBV Technologies operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALCYBCybergun
      0.0002 €
      (100.00%)
      		15.76M
      DMSBSDiagnostic Medical Systems
      0.0065 €
      (44.44%)
      		2.05k
      ALTROTronic s Microsystems
      5.35 €
      (37.18%)
      		41
      ALNMRNamR SA
      0.43 €
      (25.00%)
      		48.93k
      ALAGOEPango SA
      0.2185 €
      (25.00%)
      		3.81M
      BIODSBiosynex DS
      0.0574 €
      (-48.75%)
      		48.99k
      DRVDSDrone Volt DS
      0.0004 €
      (-33.33%)
      		630.23k
      MLSMLSmalto
      0.0155 €
      (-24.39%)
      		50
      ALALOAcheterLouerFR
      0.0418 €
      (-18.83%)
      		318.15k
      ALARFAdeunis
      0.752 €
      (-18.26%)
      		240
      ATOAtos SE
      0.0022 €
      (4.76%)
      		547.69M
      BCPBanco Comercial Portugues SA
      0.5026 €
      (-2.48%)
      		39.61M
      ALCYBCybergun
      0.0002 €
      (100.00%)
      		15.76M
      ALVERVergnet
      0.0013 €
      (-7.14%)
      		7.49M
      ALADOAdomos
      0.0002 €
      (0.00%)
      		5.95M

      Discussion

      View Full Feed
      prototype_101 prototype_101 5 minutes ago
      X, Nvidia and tech futures getting clobbered due to new cheap Chinese AI model, sounds suspect news to me!

      Nvidia (NVDA) Slips after Chinese Startup Builds AI Model for only $5.6M
      December 27, 2024 — 12:51 pm EST

      Written by Vince Condarcuri for TipRanks ->
      NVDA
      stocktowatch stocktowatch 6 minutes ago
      $CSDX @MedusaSdp
      comes in two powerful smart solutions;
      ✔️Alcohol-Based: Fast action and broad-spectrum defense. Ideal for high-traffic areas like hospitals, clinics and industrial areas.
      ✔️Alcohol-Free: Eco-friendly. Gentle yet highly effective for sensitive spaces, eco-consci
      CSDX
      RickNagra RickNagra 6 minutes ago
      Above $7 this week and possibly even $8.
      style="font-size: 1em"

      style="font-size: 1em"Also I am reading that a lot of investors here in the USA and Canada are having trouble buying GSEs because of the OTC market place.  USA problem is easy to fix just go through ETrade.  C
      FNMA
      Iggy_Bot Iggy_Bot 6 minutes ago
      Just like you were screaming .0020 as it took off to .0080,
      your only back trying to save face cause it looks like a down day for the markets
      but that don't mean we will go down.. you 🤡's need a new game
      GVSI
      Jake731 Jake731 6 minutes ago
      GOOD MORNING ALL. 






      TPTW……!!!!!!!!
      TPTW
      The_Edge The_Edge 7 minutes ago
      Nice concept, name and good reviews.. Trading at 1.66 x price to sales as of now .. will keep on watch
      chrismiss_everyday chrismiss_everyday 7 minutes ago
      Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

      NEW YORK – January 27, 2025
      Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-sta
      AVXL
      100lbStriper 100lbStriper 8 minutes ago
      CAFC filing dates for NLST patent and litigation appeals
      https://i.redd.it/ygckv8cr42fe1.png

      CAFC Patent Validity decisions within an average of 18-24 months (consolidation with applicable trial appeals could extend the timeframe)

      * 523 Filed 07/23 - earlier than
      NLST
      Margin Buu Margin Buu 8 minutes ago
      That’s rich.
      NWBO
      worthylion worthylion 8 minutes ago
      CCEL Based on last quarter's schedule, should announce another .25 quarterly dividend this week or a 13.2% annual yield at current price. Maybe a good play in what could be a shaky market this week. 
      WandererHero90 WandererHero90 8 minutes ago
      Right place, right time! It would be a tremendous bungle for LWLG to NOT benefit significantly from this profound paradigm shift:

      https://www.securities.io/can-photonics-keep-moores-law-alive/
      LWLG
      OPKOHEALTH2022 OPKOHEALTH2022 9 minutes ago
      $7’s today ! Where is the paid pumper ?
      FCEL
      sab63090 sab63090 9 minutes ago
      Here we go again: Showcasing, patches, etc. how do you guys feel?
      AVXL
      cottonmather cottonmather 10 minutes ago
      Steve Gardner. Trump and the CIA. Good video. 43 minutes https://youtu.be/-fM6AnZnDZ0?si=PkjK9BkT8PQjwq7h
      Nelson2 Nelson2 10 minutes ago
      Hold on to the guard rails boyz
      I believe today may be a rough ride

      GLTA
      BB
      maryj55555 maryj55555 11 minutes ago
      if they do max it out at 5 billion - fake scams with 14billion have run well past .01 and beyond. This company with revs and maybe the tech to be a solid company can do it no problem. I'll take my chances. Good luck to you trader69. 
      TKMO
      All City Baby All City Baby 11 minutes ago
      Don't you think it's suspect that some random website (gurufocus.com) is claiming Dr. Lippa owns shares in a lithium company with a stock symbol the same as RespireRx's predecessor, Cortex Pharmaceuticals?
      RSPI
      Invest-in-America Invest-in-America 11 minutes ago
      TVGN: Identical news they had on 1-24-25. (And their FLOAT is too big.)
      TVGN
      SkeBallLarry SkeBallLarry 11 minutes ago
      Nasdaq futures down almost 900 pts .. !!
      SkeBallLarry SkeBallLarry 12 minutes ago
      Nasdaq futures down almost 900 pts .. !!
      RickNagra RickNagra 13 minutes ago
      Big day today.

      https://thehill.com/homenews/senate/5106707-scott-bessent-treasury-senate-advances/
      FNMA
      SkeBallLarry SkeBallLarry 13 minutes ago
      Nasdaq futures down almost 900 pts .. !!
      rolvram rolvram 14 minutes ago
      Citi Reiterates Buy Rating on $NVDA, PT $175

      Analyst comments: "Recently, DeepSeek’s R1, a China-made LLM prompted investor inquiries around cost of compute as it announced to use just a fraction of its US competitors’ cost and still achieved top performance. While DeepSeek’s achievem
      NVDA
      diamondguru-one diamondguru-one 14 minutes ago
      Hmmmmm Raise it to 850 Billion SHARES ???? WHY ???? is something HUGE COMING ?????

      PR is out today Nov.9 and like I said THREE synergistic, established & profitable acquisitions will follow:
      "Upon their review of our response today; we expect to be reinstated to that of PINK
      GNCP MSB PDIV
      SkeBallLarry SkeBallLarry 15 minutes ago
      Nasdaq futures down almost 900 pts .. !!

      Your Recent History

      EU
      DBV
      DBV Technologies
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads